| Predicate |
Object |
| contentType |
Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't |
| endingPage |
158 |
| issn |
0031-6970
1432-1041 |
| issueIdentifier |
2 |
| pageRange |
151-158 |
| publicationName |
European Journal of Clinical Pharmacology |
| startingPage |
151 |
| bibliographicCitation |
van Giersbergen PLM, Dingemanse J. Tolerability, pharmacokinetics, and pharmacodynamics of clazosentan, a parenteral endothelin receptor antagonist. European Journal of Clinical Pharmacology. 2006 Apr 25;63(2):151–8. doi: 10.1007/s00228-006-0117-z. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db2ab8e85f776afbe91a6f77ad8c4932
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6dac5c98be0aad4ebb37cd9a579bdde2 |
| date |
2006-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/16636870
https://doi.org/10.1007/s00228-006-0117-z |
| isPartOf |
https://portal.issn.org/resource/ISSN/1432-1041
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3612
https://portal.issn.org/resource/ISSN/0031-6970 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/ |
| title |
Tolerability, pharmacokinetics, and pharmacodynamics of clazosentan, a parenteral endothelin receptor antagonist |
| discusses |
http://id.nlm.nih.gov/mesh/M0018233
http://id.nlm.nih.gov/mesh/M0018260
http://id.nlm.nih.gov/mesh/M0028780
http://id.nlm.nih.gov/mesh/M0587498
http://id.nlm.nih.gov/mesh/M0020790
http://id.nlm.nih.gov/mesh/M0499083
http://id.nlm.nih.gov/mesh/M0021253
http://id.nlm.nih.gov/mesh/M0006497 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16212950
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9614
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8593
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7907
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8e38613f28d11a079c0276d233e37ef4
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6433095 |